← Leaderboards
Kathleen C. Torkko
University Of Colorado Denver
$228,447
Attributed
$228,447
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $114.8K · FY2010–11$200K$150K$100K$50K$0
'10
'11
Funding mix
By agency
NIH$228,447 · 1
By mechanism
R01$228,447 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Firouz Daneshgari$10,050,590
- E David Crawford$6,974,306
- Robin Shandas$12,521,834
- M S Lucia$12,597,585
- Cheryl Lynne Ackert-Bicknell$7,745,724
Others in their field
Top investigators on “Adrenergic Antagonists”
- Scott T Weiss · University Of California, San Diego$16,158,162
- Bruce M Psaty · University Of Washington$14,073,031
- Brian K Kobilka · Stanford University$9,513,106
- Herbert David Kleber · New York State Psychiatric Institute$8,983,143
- Lynn A Sleeper · New England Research Institutes, Inc.$8,654,163
- Sharon L Tennstedt · New England Research Institutes, Inc.$8,654,163
Research focus
Adrenergic AntagonistsAmericanAncillary StudyAngiogenesisApoptosisBaseBenignBenign Prostatic HypertrophyBiomarkerBiopsyBiopsy SpecimenCaspase-3Cd34 GeneCd4 Positive T LymphocytesCd8b1 GeneCell DensityCell ProliferationCellsChronicCicatrixClinical DataClinical TrialsColoradoCombined Modality Therapy